New medication for hot flashes in perimenopausal women
Part of Women’s health & pregnancy clinical trials.
This study tests whether a new medication (CL25216) can help reduce hot flashes and other menopause symptoms in women going through perimenopause. It is specifically for overweight women who are still having irregular periods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 40 and 55 years old who is overweight (BMI 25–29).
- You have noticed changes in your period for at least 3 months (irregular cycles, with more than 7 days difference in length).
- You still have your uterus and both ovaries.
- You have not used hormone therapy or any herbal products for menopause in the last 6 months.
- You have no history of blood clots, stroke, heart attack, or certain cancers, and you are not currently taking blood thinners.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called asimadoline to see if it can reduce hot flashes and night sweats in women going through menopause. It may help women who have frequent, bothersome symptoms and are not currently using other treatments for them.
This study looks at how menopausal hormone therapy affects the brain and heart during menopause. It aims to see if starting hormone therapy can help improve heart and brain health in women with bothersome hot flashes.
This trial tests a new supplement, CL25216, to see if it helps balance hormones and reduce period pain. It is for women who have regular periods but suffer from painful cramps.
This study tests an oral product to see if it can help with menopause symptoms like hot flashes. It is for women aged 40–65 who still have a uterus and are not on hormone therapy.
This study tests a medication called fezolinetant to see if it helps with hot flashes and also looks at its effects on blood vessels and the brain. It is for women who are going through menopause and having frequent moderate to severe hot flashes.
This study tests a new treatment for women going through menopause who have frequent hot flashes. It aims to find a safe and effective way to reduce moderate to severe hot flashes.
Hear when a new Vasomotor Symptoms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.